Quarterly report pursuant to Section 13 or 15(d)

INVESTMENT IN DEBT AND EQUITY SECURITIES (Details Narrative)

v3.24.1
INVESTMENT IN DEBT AND EQUITY SECURITIES (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Nov. 14, 2023
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Securities Financing Transaction [Line Items]          
Gain (loss) on investment   $ (416,000) $ 0 $ (416,000) $ 0
Gain (Loss) on Investments   416,000 $ 0 416,000 $ 0
Femasys Note [Member]          
Securities Financing Transaction [Line Items]          
Investment fair value $ 1,874,000        
Gain (loss) on investment   138,000   138,000  
Gain (Loss) on Investments   (138,000)   (138,000)  
Femasys Warrants [Member]          
Securities Financing Transaction [Line Items]          
Investment fair value 3,126,000        
Gain (loss) on investment   (416,000)   (416,000)  
Gain (Loss) on Investments   $ 416,000   $ 416,000  
Femasys Purchase Agreement [Member]          
Securities Financing Transaction [Line Items]          
Receivable face amount $ 5,000,000        
Receivable conversion price $ 1.18        
Investment description The Femasys Notes accrue interest at 6.0% per annum, payable annually, and mature two years after the date of issuance.        
Femasys Warrant description The Femasys Warrants expire five years from the date of issuance.        
Femasys Purchase Agreement [Member] | Femasys Series A Warrants [Member]          
Securities Financing Transaction [Line Items]          
Warrant assets, shares 4,237,288        
Warrant exercise price $ 1.18        
Femasys Purchase Agreement [Member] | Femasys Shares [Member]          
Securities Financing Transaction [Line Items]          
Receivable conversion price $ 1.475        
Investment shares 4,237,288